Ghent University Academic Bibliography

Journal Article
A1
open access

Glofitamab in relapsed/refractory mantle cell lymphoma : results from a phase I/II study

Tycel Jovelle Phillips, Carmelo Carlo-Stella, Franck Morschhauser, Emmanuel Bachy, Michael Crump, Marek Trneny, Nancy L. Bartlett, Jan Zaucha, Tomasz Wrobel, Fritz Offner (UGent) , et al.

(2025) JOURNAL OF CLINICAL ONCOLOGY. 43(3). p.318-328

Add to list

Conference Paper

ELARA Phase 2 Clinical Outcomes for Tisagenlecleucel in Patients With High-Risk Relapsed/Refractory Follicular Lymphoma: 4-Year Update

Catherine Thieblemont, Martin Dreyling, Michael J. Dickinson, Joaquin Martinez-Lopez, Arne Kolstad, Jason Butler, Monalisa Ghosh, Leslie L. Popplewell, Julio C. Chavez, Emmanuel Bachy, et al.

(2025) CLINICAL LYMPHOMA MYELOMA & LEUKEMIA. 25.

Add to list

Conference Paper
open access

Clinical outcomes of tisagenlecleucel in patients with relapsed/refractory follicular lymphoma (r/r FL): Phase 2 ELARA 5-year update

Stephen Schuster, Catherine Thieblemont, Michael Dickinson, Joaquin Martinez-Lopez, Arne Kolstad, Jason Butler, Monalisa Ghosh, Leslie Popplewell, Julio Chavez, Emmanuel Bachy, et al.

(2025) BLOOD. 146. p.468-469

Add to list

Glofitamab monotherapy retreatment in patients with heavily pre-treated relapsed or refractory (R/R) non-Hodgkin lymphoma (NHL) : results from a phase I/II study

Nancy L. Bartlett, Michael Dickinson, Martin Hutchings, Carmelo Carlo-Stella, Shang-Ju Wu, Sirpa Leppa, Marek Trneny, Paolo Corradini, Fritz Offner (UGent) , Estefania Mulvihill, et al.

(2024) JOURNAL OF CLINICAL ONCOLOGY. In Journal of Clinical Oncology 42(16, Supplement S).

Add to list

Glofitamab monotherapy in patients with heavily pretreated relapsed/refractory (R/R) mantle cell lymphoma (MCL) : updated analysis from a phase 1/2 study

Tycel Phillips, Carmelo Carlo-Stella, Franck Morschhauser, Emmanuel Bachy, Michael Crump, Marek Trneny, Nancy L. Bartlett, Jan Zaucha, Tomasz Wrobel, Fritz Offner (UGent) , et al.

(2024) CLINICAL LYMPHOMA MYELOMA & LEUKEMIA. In Clinical Lymphoma Myeloma & Leukemia 24(Supplement 1). p.S515-S516

Add to list

Glofitamab monotherapy in patients with heavily pretreated relapsed/refractory (R/R) mantle cell lymphoma (MCL) : updated analysis from a phase I/II study

Tycel Jovelle Phillips, Carmelo Carlo-Stella, Franck Morschhauser, Emmanuel Bachy, Michael Crump, Marek Trneny, Nancy L. Bartlett, Jan Zaucha, Tomasz Wrobel, Fritz Offner (UGent) , et al.

(2024) JOURNAL OF CLINICAL ONCOLOGY. In Journal of Clinical Oncology 42(16, Supplement S).

Add to list

Clinical outcomes of patients with high-risk relapsed/refractory follicular lymphoma treated with tisagenlecleucel : phase 2 ELARA 4-year update

Catherine Thieblemont, Martin Dreyling, Michael J. Dickinson, Joaquin Martinez-Lopez, Arne Kolstad, Jason Butler, Monalisa Ghosh, Leslie L. Popplewell, Julio C. Chavez, Emmanuel Bachy, et al.

(2024) BLOOD. In Blood 144(Supplement 1). p.3034-3037

Add to list

Clinical outcomes of patients with relapsed/refractory follicular lymphoma (R/R FL) treated with tisagenlecleucel : phase 2 ELARA 3-year follow-up

Stephen J. Schuster, Nathan Hale Fowler, Michael Dickinson, Joaquin Martinez-Lopez, Arne Kolstad, Jason Butler, Monalisa Ghosh, Leslie Popplewell, Julio C. Chavez, Emmanuel Bachy, et al.

(2024) CLINICAL LYMPHOMA MYELOMA & LEUKEMIA. In Clinical Lymphoma Myeloma & Leukemia 24(Supplement 1). p.S495-S496

Add to list

Journal Article
A1
open access

Durable response after tisagenlecleucel in adults with relapsed/refractory follicular lymphoma : ELARA trial update

Martin Dreyling, Nathan Hale Fowler, Michael Dickinson, Joaquin Martinez-Lopez, Arne Kolstad, Jason Butler, Monalisa Ghosh, Leslie Popplewell, Julio C. Chavez, Emmanuel Bachy, et al.

(2024) BLOOD. 143(17). p.1713-1725

Add to list

Tisagenlecleucel in adult relapsed or refractory follicular lymphoma : the phase 2 ELARA trial

Nathan Hale Fowler, Michael Dickinson, Martin Dreyling, Joaquin Martinez-Lopez, Arne Kolstad, Jason Butler, Monalisa Ghosh, Leslie Popplewell, Julio C. Chavez, Emmanuel Bachy, et al.

(2022) NATURE MEDICINE. 28(2). p.325-332

Academic Bibliography

Glofitamab in relapsed/refractory mantle cell lymphoma : results from a phase I/II study

ELARA Phase 2 Clinical Outcomes for Tisagenlecleucel in Patients With High-Risk Relapsed/Refractory Follicular Lymphoma: 4-Year Update

Clinical outcomes of tisagenlecleucel in patients with relapsed/refractory follicular lymphoma (r/r FL): Phase 2 ELARA 5-year update

Glofitamab monotherapy retreatment in patients with heavily pre-treated relapsed or refractory (R/R) non-Hodgkin lymphoma (NHL) : results from a phase I/II study

Glofitamab monotherapy in patients with heavily pretreated relapsed/refractory (R/R) mantle cell lymphoma (MCL) : updated analysis from a phase 1/2 study

Glofitamab monotherapy in patients with heavily pretreated relapsed/refractory (R/R) mantle cell lymphoma (MCL) : updated analysis from a phase I/II study

Clinical outcomes of patients with high-risk relapsed/refractory follicular lymphoma treated with tisagenlecleucel : phase 2 ELARA 4-year update

Clinical outcomes of patients with relapsed/refractory follicular lymphoma (R/R FL) treated with tisagenlecleucel : phase 2 ELARA 3-year follow-up

Durable response after tisagenlecleucel in adults with relapsed/refractory follicular lymphoma : ELARA trial update

Tisagenlecleucel in adult relapsed or refractory follicular lymphoma : the phase 2 ELARA trial

Contents

Support

Contact